TransVIHMI, UMI 233, Institut de Recherche pour le Développement (IRD)-Université Montpellier 1, Montpellier, France.
Expert Rev Anti Infect Ther. 2013 Sep;11(9):885-96. doi: 10.1586/14787210.2013.825443. Epub 2013 Sep 9.
HIV-1 in humans resulted from at least four cross-species transmissions of simian immunodeficiency viruses (SIVs) from chimpanzees and gorillas in West Central Africa, while HIV-2 viruses resulted from at least eight independent transmissions of SIVs infecting sooty mangabeys in West Africa only, where one of these transmissions (HIV-1 group M) is responsible for the global epidemic. HIV-1 M is subdivided into nine subtypes and a wide diversity of circulating recombinant forms (CRFs) and unique recombinant forms. The heterogenic HIV-1 M subtype/CRF distribution is the result of founder effects. The genetic diversity of HIV-1 continues to increase overtime due to demographic factors such as travel and migration and frequent co/superinfections. In addition, the expanded access to antiretrovirals leads to an increasing number of drug-resistant strains, especially in resource limited countries.
人类 HIV-1 至少源自来自中非西部的黑猩猩和大猩猩的灵长类免疫缺陷病毒(SIVs)的 4 次跨物种传播,而 HIV-2 病毒则至少源自西非感染黑眉长尾猴的 8 次独立的 SIV 传播,其中一次传播(HIV-1 组 M)导致了全球流行。HIV-1 M 分为 9 个亚型以及广泛的循环重组形式(CRFs)和独特的重组形式。HIV-1 M 亚型/CRF 的异质性分布是创始效应的结果。由于旅行和迁移等人口因素以及经常的合并/混合感染,HIV-1 的遗传多样性会随着时间的推移而不断增加。此外,由于获得抗逆转录病毒药物的机会增加,耐药株的数量也在不断增加,尤其是在资源有限的国家。